#Open journalism No news is bad news

Your contributions will help us continue to deliver the stories that are important to you

Support The Journal
Dublin: 2°C Thursday 21 January 2021
Advertisement

Qantas boss says passengers will have to prove they have received a Covid-19 vaccine in order to travel

Alan Joyce said the jab will be a “necessity” for travellers.

Image: Xinhua News Agency/PA Images

THE HEAD OF airline Qantas has said that people who want to travel internationally in the future will have to provide proof that they have received the Covid-19 vaccination.

Alan Joyce, who previously worked for Aer Lingus, described how his company is looking to amend their current terms and conditions to make it mandatory for anyone wanting to travel to prove they have been inoculated.

He told Australia’s Channel 9: “We are looking at changing our terms and conditions to say for international travellers that we will ask people to have a vaccination before they can get on the aircraft.

“For international travellers, we will ask people to have a vaccination before they get on the aircraft,’’ he said.

“Certainly, for international visitors coming out and people leaving the country we think that’s a necessity.

“I think that’s going to be a common thing talking to my colleagues in other airlines around the globe.”

Joyce said he expects the airline industry to return to relative normality by the end of next year, depending on if the vaccines currently being trialled are effective. 

He explained: “Unfortunately with the levels of the virus in the United States and in Europe, we’re not going to see operations to those destinations in any real strength until we see a vaccine being rolled out, which is likely towards the end of 2021.”

#Open journalism No news is bad news Support The Journal

Your contributions will help us continue to deliver the stories that are important to you

Support us now

Earlier this month, pharma firm Modern announced its experimental vaccine against Covid-19 was shown to be 94.5%  effective according to early results from a clinical trial with more than 30,000 participants.

“This positive interim analysis from our Phase 3 study has given us the first clinical validation that our vaccine can prevent Covid-19 disease, including severe disease,” said Stephane Bancel, Moderna’s CEO.

There are also several other vaccines currently being trialled with early data showing widespread efficacy. 

About the author:

Read next:

COMMENTS (84)

This is YOUR comments community. Stay civil, stay constructive, stay on topic. Please familiarise yourself with our comments policy here before taking part.
write a comment

    Leave a commentcancel